首页 > 最新文献

Journal of immunological sciences最新文献

英文 中文
Polio Outbreak Investigation and Response in The Horn of Africa: 2013-2016. 非洲之角脊髓灰质炎疫情调查和应对:2013-2016年。
Pub Date : 2021-04-07 DOI: 10.29245/2578-3009/2021/S2.1104
Samuel Okiror, Abraham Mulugeta, Iheoma Onuekwusi, Fiona Braka, Sylvesta Malengemi, John Burton, Rustam Hydarav, Brigitte Toure, Bob Davis, Carolyn Gathenji, Chidiadi Nwogu, Joseph Okeibunor

Background: There has been civil strife, spanning more than two decades in some countries and recurrent natural disasters in the Horn of Africa (HoA). This has consistently maintained these countries in chronic humanitarian conditions. More important however is the fact that these crises have also denied populations of these countries access to access to lifesaving health services. Children in the difficult terrains and security compromised areas are not given the required immunization services to build their immunity against infectious diseases like the poliovirus. This was the situation in 2013 when the large outbreaks of poliovirus occurred in the HoA. This article reviews the epidemiology, risk, and programme response to what is now famed as the 2013-204 poliovirus outbreaks in the HoA and highlights the challenges that the programme faced in interrupting poliovirus transmission here.

Methods: A case of acute flaccid paralysis (AFP) was defined as a child <15 years of age with sudden onset of fever and paralysis. Polio cases were defined as AFP cases with stool specimens positive for WPV.

Results: Between 2013 and 2016, when transmission was interrupted 20,266 polio viruses were in the Horn of Africa region. In response to the outbreak, several supplementary immunization activities were conducted with oral polio vaccine (OPV) The trivalent OPV was used initially, followed subsequently by bivalent OPV, and targeting various age groups, including children aged <5 years, children aged <10 years, and individuals of any age. Other response activities were undertaken to supplement the immunization in controlling the outbreak. Some of these activities included the use of various communication strategies to create awareness, sensitize and mobilize the populations against poliovirus transmission.

Conclusions: The outbreaks were attributed to the existence of clusters of unvaccinated children due to inaccessibility to them by the health system, caused by poor geographical terrain and conflicts. The key lesson therefore is that the existence of populations with low immunity to infections will necessary constitutes breeding grounds for disease outbreak and of course reservoirs to the vectors. Though brought under reasonable control, the outbreaks indicate that the threat of large polio outbreaks resulting from poliovirus importation will remain constant unless polio transmission is interrupted in the remaining polio-endemic countries of the world.

背景:一些国家的内乱持续了20多年,非洲之角(HoA)的自然灾害频繁发生。这使这些国家长期处于人道主义状况。然而,更重要的是,这些危机也使这些国家的人民无法获得挽救生命的卫生服务。在困难地形和安全受到威胁地区的儿童没有获得必要的免疫服务,以建立对脊髓灰质炎病毒等传染病的免疫力。这就是2013年在HoA发生大规模脊髓灰质炎病毒暴发时的情况。本文回顾了世卫组织2013-204年脊髓灰质炎病毒暴发的流行病学、风险和规划应对情况,并强调了世卫组织在阻断脊髓灰质炎病毒传播方面面临的挑战。结果:2013年至2016年,当传播中断时,非洲之角地区共发现20,266种脊髓灰质炎病毒。为应对疫情,开展了几次口服脊髓灰质炎疫苗(OPV)补充免疫活动,最初使用三价口服脊髓灰质炎疫苗,随后使用二价口服脊髓灰质炎疫苗,并针对不同年龄组,包括老年儿童。结论:疫情的原因是由于地理地形恶劣和冲突导致卫生系统无法接近未接种疫苗的儿童。因此,关键的教训是,对感染免疫力低下的人群的存在必然会构成疾病爆发的滋生地,当然也是病媒的宿主。尽管疫情得到了合理控制,但这些疫情表明,除非在世界上剩余的脊髓灰质炎流行国家阻断脊髓灰质炎的传播,否则由脊髓灰质炎病毒输入引起的大规模脊髓灰质炎疫情的威胁将继续存在。
{"title":"Polio Outbreak Investigation and Response in The Horn of Africa: 2013-2016.","authors":"Samuel Okiror,&nbsp;Abraham Mulugeta,&nbsp;Iheoma Onuekwusi,&nbsp;Fiona Braka,&nbsp;Sylvesta Malengemi,&nbsp;John Burton,&nbsp;Rustam Hydarav,&nbsp;Brigitte Toure,&nbsp;Bob Davis,&nbsp;Carolyn Gathenji,&nbsp;Chidiadi Nwogu,&nbsp;Joseph Okeibunor","doi":"10.29245/2578-3009/2021/S2.1104","DOIUrl":"https://doi.org/10.29245/2578-3009/2021/S2.1104","url":null,"abstract":"<p><strong>Background: </strong>There has been civil strife, spanning more than two decades in some countries and recurrent natural disasters in the Horn of Africa (HoA). This has consistently maintained these countries in chronic humanitarian conditions. More important however is the fact that these crises have also denied populations of these countries access to access to lifesaving health services. Children in the difficult terrains and security compromised areas are not given the required immunization services to build their immunity against infectious diseases like the poliovirus. This was the situation in 2013 when the large outbreaks of poliovirus occurred in the HoA. This article reviews the epidemiology, risk, and programme response to what is now famed as the 2013-204 poliovirus outbreaks in the HoA and highlights the challenges that the programme faced in interrupting poliovirus transmission here.</p><p><strong>Methods: </strong>A case of acute flaccid paralysis (AFP) was defined as a child <15 years of age with sudden onset of fever and paralysis. Polio cases were defined as AFP cases with stool specimens positive for WPV.</p><p><strong>Results: </strong>Between 2013 and 2016, when transmission was interrupted 20,266 polio viruses were in the Horn of Africa region. In response to the outbreak, several supplementary immunization activities were conducted with oral polio vaccine (OPV) The trivalent OPV was used initially, followed subsequently by bivalent OPV, and targeting various age groups, including children aged <5 years, children aged <10 years, and individuals of any age. Other response activities were undertaken to supplement the immunization in controlling the outbreak. Some of these activities included the use of various communication strategies to create awareness, sensitize and mobilize the populations against poliovirus transmission.</p><p><strong>Conclusions: </strong>The outbreaks were attributed to the existence of clusters of unvaccinated children due to inaccessibility to them by the health system, caused by poor geographical terrain and conflicts. The key lesson therefore is that the existence of populations with low immunity to infections will necessary constitutes breeding grounds for disease outbreak and of course reservoirs to the vectors. Though brought under reasonable control, the outbreaks indicate that the threat of large polio outbreaks resulting from poliovirus importation will remain constant unless polio transmission is interrupted in the remaining polio-endemic countries of the world.</p>","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38953117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Simulation Exercises To Strengthen Polio Outbreak Preparedness in The Horn of Africa: Experiences and Lessons Learnt. 加强非洲之角预防脊髓灰质炎爆发的模拟演习:经验教训。
Pub Date : 2021-04-05 DOI: 10.29245/2578-3009/2021/S2.1107
Samuel Okiror, Chidiadi Nwogu, Obianuju Igweonu, Rustam Hydarov, Djiboui Karim, Farkhard Imambakiev, John Ogange, Annet Kisakye, Joseph Okeibunor, Hemant Shukla

Background: Poliovirus importations and related outbreaks occurred in the Horn of Africa (HoA) following an initial outbreak, which started in Somalia, spread into Kenya within ten days and later into Ethiopia and gradually to other countries in the region. National preparedness plans for responding to poliovirus introduction were insufficient in many countries of the Region. We describe a series of polio outbreak simulation exercises that were implemented to formally test polio outbreak preparedness plans in the HoA countries, as a step to interrupting further transmission.

Methods: The Polio Outbreak Simulation Exercises (POSEs) were designed and implemented. The results were evaluated and recommendations made. The roles of outbreak simulation exercises in maintaining regional polio-free status were assessed. In addition, we performed a comprehensive review of the national plans of all for seven countries in the HoA Region.

Results: Seven simulation exercises, delivered between 2016 and 2017 revealed that participating countries were generally prepared for poliovirus introduction, but the level of preparedness needed improvement. The areas in particular need of strengthening were national preparedness plans, initial response, plans for securing vaccine supply, and communications.

Conclusions: Polio outbreak simulation exercises can be valuable tools to help maintain polio-free status and should be extended to other high-risk countries and subnational areas in the HoA Region and elsewhere. There is also need to standardize the process and methods for conducting POSE for comparability.

背景:脊髓灰质炎病毒输入和相关暴发发生在非洲之角,最初在索马里暴发,在10天内蔓延到肯尼亚,后来蔓延到埃塞俄比亚,并逐渐蔓延到该区域的其他国家。本区域许多国家应对脊髓灰质炎病毒传入的国家防备计划不足。我们描述了在HoA国家实施的一系列脊髓灰质炎暴发模拟演习,以正式测试脊髓灰质炎暴发准备计划,作为阻断进一步传播的一个步骤。方法:设计并实施脊髓灰质炎暴发模拟演习。评估了结果并提出了建议。评估了疫情模拟演习在维持区域无脊髓灰质炎状态方面的作用。此外,我们全面审查了人道主义事务部区域七个国家的国家计划。结果:2016年至2017年期间进行的七次模拟演习显示,参与国总体上为脊髓灰质炎病毒的引入做好了准备,但准备水平有待提高。特别需要加强的领域是国家防备计划、初步反应、确保疫苗供应的计划和通信。结论:脊髓灰质炎暴发模拟演习可成为帮助维持无脊髓灰质炎状态的宝贵工具,应推广到其他高风险国家和人道主义事务区域及其他地方的次国家地区。还需要对进行POSE的过程和方法进行标准化,以实现可比性。
{"title":"Simulation Exercises To Strengthen Polio Outbreak Preparedness in The Horn of Africa: Experiences and Lessons Learnt.","authors":"Samuel Okiror,&nbsp;Chidiadi Nwogu,&nbsp;Obianuju Igweonu,&nbsp;Rustam Hydarov,&nbsp;Djiboui Karim,&nbsp;Farkhard Imambakiev,&nbsp;John Ogange,&nbsp;Annet Kisakye,&nbsp;Joseph Okeibunor,&nbsp;Hemant Shukla","doi":"10.29245/2578-3009/2021/S2.1107","DOIUrl":"https://doi.org/10.29245/2578-3009/2021/S2.1107","url":null,"abstract":"<p><strong>Background: </strong>Poliovirus importations and related outbreaks occurred in the Horn of Africa (HoA) following an initial outbreak, which started in Somalia, spread into Kenya within ten days and later into Ethiopia and gradually to other countries in the region. National preparedness plans for responding to poliovirus introduction were insufficient in many countries of the Region. We describe a series of polio outbreak simulation exercises that were implemented to formally test polio outbreak preparedness plans in the HoA countries, as a step to interrupting further transmission.</p><p><strong>Methods: </strong>The Polio Outbreak Simulation Exercises (POSEs) were designed and implemented. The results were evaluated and recommendations made. The roles of outbreak simulation exercises in maintaining regional polio-free status were assessed. In addition, we performed a comprehensive review of the national plans of all for seven countries in the HoA Region.</p><p><strong>Results: </strong>Seven simulation exercises, delivered between 2016 and 2017 revealed that participating countries were generally prepared for poliovirus introduction, but the level of preparedness needed improvement. The areas in particular need of strengthening were national preparedness plans, initial response, plans for securing vaccine supply, and communications.</p><p><strong>Conclusions: </strong>Polio outbreak simulation exercises can be valuable tools to help maintain polio-free status and should be extended to other high-risk countries and subnational areas in the HoA Region and elsewhere. There is also need to standardize the process and methods for conducting POSE for comparability.</p>","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610728/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38953118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overview of Polio Outbreak Response in Kenya, 2013 to 2015. 2013年至2015年肯尼亚脊灰疫情应对概述。
Pub Date : 2021-04-02 DOI: 10.29245/2578-3009/2021/S2.1103
Chidiadi Nwogu, Johnny Musyoka, Carolyne Gathenji, Rosemary Nzunza, Iheoma Onuekwusi, Joseph Okeibunor, Pascal Mkanda, Hemant Shukla, Shaikh Humayun Kabir, Sam O Okiror

Background: Globally, tremendous improvement has been made in Polio eradication since its inception in 1988. For the third time in a decade, Kenya has experienced a Polio outbreak along the border with Somalia. The affected areas were in Garissa County, replete with previous occurrences in 2006 and 2012. This article, give an account of series of events and activities that were used to stop the transmission within 13 weeks, an interval between the first and the last case of the 2013 outbreak.

Methods: In an attempt to stop further transmission and time bound closure of the outbreak, many activities were brought to fore: the known traditional methods, innovative approaches, improved finances and surge capacity. These assisted in case detection, implementation, and coordination of activities. The external outbreak assessments and the six-monthly technical advisory group recommendations were also employed.

Result: There were increased case detections of >=2/100,000, stool adequacy >=80%, due to enhanced surveillance, timely feedbacks from laboratory investigation and diagnosis. Sustained coverage in supplemental immunisation of > 90%, ensured that immune profile of >=3 polio vaccine doses was quickly attained to protect the targeted population, prevent further polio infection and eventual reduction of cases coming up with paralysis.

Conclusion: Overall, the outbreak was stopped within the 120 days of the first case using 14 rounds of supplemental immunisation activities.

背景:在全球范围内,自1988年开始根除脊髓灰质炎以来取得了巨大进展。十年来,肯尼亚在与索马里接壤的边境地区第三次爆发小儿麻痹症。受影响的地区位于加里萨县,此前曾在2006年和2012年发生过霍乱。本文叙述了用于在13周(2013年暴发的第一例和最后一例之间的间隔)内阻止传播的一系列事件和活动。方法:为了阻止进一步传播和有时间限制地结束疫情,开展了许多活动:已知的传统方法、创新办法、改善财政状况和应急能力。这些机构协助发现病例、实施和协调各项活动。还采用了外部疫情评估和六个月技术咨询小组的建议。结果:由于监测加强,实验室调查和诊断反馈及时,大便充分率>=80%,检出率>=2/10万增加。补充免疫的持续覆盖率达到90%,确保迅速达到>=3脊髓灰质炎疫苗剂量的免疫水平,以保护目标人群,防止进一步的脊髓灰质炎感染,并最终减少瘫痪病例。结论:总体而言,通过14轮补充免疫活动,在首例病例发生后120天内遏制了疫情。
{"title":"Overview of Polio Outbreak Response in Kenya, 2013 to 2015.","authors":"Chidiadi Nwogu, Johnny Musyoka, Carolyne Gathenji, Rosemary Nzunza, Iheoma Onuekwusi, Joseph Okeibunor, Pascal Mkanda, Hemant Shukla, Shaikh Humayun Kabir, Sam O Okiror","doi":"10.29245/2578-3009/2021/S2.1103","DOIUrl":"10.29245/2578-3009/2021/S2.1103","url":null,"abstract":"<p><strong>Background: </strong>Globally, tremendous improvement has been made in Polio eradication since its inception in 1988. For the third time in a decade, Kenya has experienced a Polio outbreak along the border with Somalia. The affected areas were in Garissa County, replete with previous occurrences in 2006 and 2012. This article, give an account of series of events and activities that were used to stop the transmission within 13 weeks, an interval between the first and the last case of the 2013 outbreak.</p><p><strong>Methods: </strong>In an attempt to stop further transmission and time bound closure of the outbreak, many activities were brought to fore: the known traditional methods, innovative approaches, improved finances and surge capacity. These assisted in case detection, implementation, and coordination of activities. The external outbreak assessments and the six-monthly technical advisory group recommendations were also employed.</p><p><strong>Result: </strong>There were increased case detections of >=2/100,000, stool adequacy >=80%, due to enhanced surveillance, timely feedbacks from laboratory investigation and diagnosis. Sustained coverage in supplemental immunisation of > 90%, ensured that immune profile of >=3 polio vaccine doses was quickly attained to protect the targeted population, prevent further polio infection and eventual reduction of cases coming up with paralysis.</p><p><strong>Conclusion: </strong>Overall, the outbreak was stopped within the 120 days of the first case using 14 rounds of supplemental immunisation activities.</p>","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610717/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38886725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19) 细胞因子风暴及其在2019冠状病毒病中的意义
Pub Date : 2020-09-01 DOI: 10.29245/2578-3009/2020/2.1190
C. Datta, A. Bhattacharjee
Corona virus disease 2019 (COVID-19), is a viral disease caused by novel corona virus known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). The disease was declared as a pandemic by the World Health Organisation (WHO) on March 11, 2020. Initial studies have shown the molecular resemblances in the receptor binding domains of SARS-CoV and SARS-CoV-2 which bind angiotensin converting enzyme 2 (ACE 2) receptors and helps the virus to enter into the host cells to cause infection. Illness caused by COVID19 ranges from mild common cold to life threatening acute respiratory distress syndrome (ARDS), multi-organ dysfunction and shock. The key step in converting mild disease to severe is immune dysfunction and cytokine dysregulation resulting in “cytokine storm syndrome”. Clinical investigations in patients with COVID-19 have shown that a strong upregulation of cytokine and interferon production is common feature in SARS-CoV2-induced pneumonia, with an associated cytokine storm syndrome. Consequently, spotting of existing approved therapies with proper safety profiles to treat hyperinflammation is very essential in order to reduce COVID-19 associated mortality. Till date, no specific therapeutic drugs or vaccines are available to treat COVID-19. In this review, we intended to describe how cytokine storm is associated with the severity of COVID-19 disease and also tried to find out the best possible way to manage the hyperinflammatory response due to cytokine storm during COVID-19 infection using several interleukin receptor antagonists, inhibitors, intravenous immunoglobulins, cytokine adsorption device and repurposing of pre-existing antiviral and some antimalarial drugs etc. Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19)
2019冠状病毒病(COVID-19)是一种由新型冠状病毒引起的病毒性疾病,称为严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)。2020年3月11日,世界卫生组织宣布新冠肺炎为大流行。初步研究表明,SARS-CoV和SARS-CoV-2在结合血管紧张素转换酶2 (ACE 2)受体并帮助病毒进入宿主细胞引起感染的受体结合域的分子相似性。covid - 19引起的疾病范围从轻度普通感冒到危及生命的急性呼吸窘迫综合征(ARDS)、多器官功能障碍和休克。免疫功能障碍和细胞因子失调导致“细胞因子风暴综合征”,是由轻病转为重症的关键步骤。对COVID-19患者的临床研究表明,细胞因子和干扰素产生的强烈上调是sars - cov2诱导的肺炎的共同特征,并伴有细胞因子风暴综合征。因此,为了降低COVID-19相关死亡率,找出具有适当安全性的现有批准疗法来治疗过度炎症是非常必要的。迄今为止,没有专门的治疗药物或疫苗可用于治疗COVID-19。在这篇综述中,我们试图描述细胞因子风暴与COVID-19疾病严重程度的关系,并试图找到控制COVID-19感染期间细胞因子风暴引起的高炎症反应的最佳方法,包括使用几种白细胞介素受体拮抗剂、抑制剂、静脉注射免疫球蛋白、细胞因子吸附装置以及重新利用已有的抗病毒药物和一些抗疟疾药物等。细胞因子风暴及其在2019冠状病毒病中的意义
{"title":"Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19)","authors":"C. Datta, A. Bhattacharjee","doi":"10.29245/2578-3009/2020/2.1190","DOIUrl":"https://doi.org/10.29245/2578-3009/2020/2.1190","url":null,"abstract":"Corona virus disease 2019 (COVID-19), is a viral disease caused by novel corona virus known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). The disease was declared as a pandemic by the World Health Organisation (WHO) on March 11, 2020. Initial studies have shown the molecular resemblances in the receptor binding domains of SARS-CoV and SARS-CoV-2 which bind angiotensin converting enzyme 2 (ACE 2) receptors and helps the virus to enter into the host cells to cause infection. Illness caused by COVID19 ranges from mild common cold to life threatening acute respiratory distress syndrome (ARDS), multi-organ dysfunction and shock. The key step in converting mild disease to severe is immune dysfunction and cytokine dysregulation resulting in “cytokine storm syndrome”. Clinical investigations in patients with COVID-19 have shown that a strong upregulation of cytokine and interferon production is common feature in SARS-CoV2-induced pneumonia, with an associated cytokine storm syndrome. Consequently, spotting of existing approved therapies with proper safety profiles to treat hyperinflammation is very essential in order to reduce COVID-19 associated mortality. Till date, no specific therapeutic drugs or vaccines are available to treat COVID-19. In this review, we intended to describe how cytokine storm is associated with the severity of COVID-19 disease and also tried to find out the best possible way to manage the hyperinflammatory response due to cytokine storm during COVID-19 infection using several interleukin receptor antagonists, inhibitors, intravenous immunoglobulins, cytokine adsorption device and repurposing of pre-existing antiviral and some antimalarial drugs etc. Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19)","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83939218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
SARS-CoV-2 Subversion of the Antiviral Interferon Alpha-Response of Lung Macrophages? SARS-CoV-2颠覆肺巨噬细胞抗病毒干扰素α反应?
Pub Date : 2020-09-01 DOI: 10.29245/2578-3009/2020/2.1189
M. Kloc, R. Ghobrial, J. Kubiak
The interferons (IFNs) are the main antiviral immune factors. Currently, various IFNs therapies are used for the treatment of human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV), cancer, and autoimmune diseases. Recently, it has been suggested that IFN-α therapy should be used to lessen the respiratory symptoms in the SARS-CoV-2 virusinfected (COVID-19) patients. The SARS-CoV-2 enters the cells by binding to the Angiotensinconverting enzyme 2 (ACE2), which by recognizing the spike S1 protein of the virus, acts as a virus receptor. Because the expression of ACE2 is induced by IFN-α, the SARS-CoV-2 virus may exploit the anti-viral response by subverting the IFN functions to further its own propagation and infectability. We discuss here how the SARS-CoV-2 may also subvert the immune response of the lung macrophages, which also express ACE2, to exacerbate the severity of the COVID-19 respiratory symptoms. SARS-CoV-2 Subversion of the Antiviral Interferon Alpha-Response of Lung Macrophages? Malgorzata Kloc1,2,3*, Rafik M. Ghobrial1,2, Jacek Z Kubiak4,5* 1The Houston Methodist Research Institute, Houston, Texas 77030, USA 2The Houston Methodist Hospital, Department of Surgery, Houston, Texas, USA 3The University of Texas, M.D. Anderson Cancer Center, Department of Genetics, Houston Texas, USA 4Laboratory of Regenerative Medicine and Cell Biology, Military Institute of Hygiene and Epidemiology (WIHE), Warsaw, Poland 5UnivRennes, UMR 6290, CNRS, Institute of Genetics and Development of Rennes, Cell Cycle Group, Faculty of Medicine, Rennes, France
干扰素(ifn)是主要的抗病毒免疫因子。目前,各种干扰素疗法被用于治疗人类免疫缺陷病毒(HIV)、乙型肝炎(HBV)和丙型肝炎(HCV)、癌症和自身免疫性疾病。最近,有人建议使用IFN-α治疗来减轻SARS-CoV-2病毒感染(COVID-19)患者的呼吸道症状。SARS-CoV-2通过与血管紧张素转换酶2 (ACE2)结合进入细胞,ACE2通过识别病毒的刺突S1蛋白,充当病毒受体。由于ACE2的表达是由IFN-α诱导的,因此SARS-CoV-2病毒可能通过破坏IFN功能来利用抗病毒应答,从而进一步促进其自身的传播和传染性。我们在这里讨论了SARS-CoV-2如何破坏同样表达ACE2的肺巨噬细胞的免疫反应,从而加剧COVID-19呼吸道症状的严重程度。SARS-CoV-2颠覆肺巨噬细胞抗病毒干扰素α反应?Malgorzata kloc1,2,3 *, Rafik M. ghobrial1,2, Jacek Z kubiak4,5 * 1休斯顿循道卫理研究所,美国德克萨斯州休斯顿77030 2休斯顿循道卫理医院外科部,美国德克萨斯州休斯顿3德克萨斯大学安德森癌症中心遗传学部,美国德克萨斯州休斯顿4再生医学和细胞生物学实验室,军事卫生和流行病学研究所(WIHE),波兰华沙5 rennes大学,UMR 6290, CNRS,雷恩遗传与发育研究所,细胞周期组,雷恩医学院,法国
{"title":"SARS-CoV-2 Subversion of the Antiviral Interferon Alpha-Response of Lung Macrophages?","authors":"M. Kloc, R. Ghobrial, J. Kubiak","doi":"10.29245/2578-3009/2020/2.1189","DOIUrl":"https://doi.org/10.29245/2578-3009/2020/2.1189","url":null,"abstract":"The interferons (IFNs) are the main antiviral immune factors. Currently, various IFNs therapies are used for the treatment of human immunodeficiency virus (HIV), hepatitis B (HBV), and hepatitis C (HCV), cancer, and autoimmune diseases. Recently, it has been suggested that IFN-α therapy should be used to lessen the respiratory symptoms in the SARS-CoV-2 virusinfected (COVID-19) patients. The SARS-CoV-2 enters the cells by binding to the Angiotensinconverting enzyme 2 (ACE2), which by recognizing the spike S1 protein of the virus, acts as a virus receptor. Because the expression of ACE2 is induced by IFN-α, the SARS-CoV-2 virus may exploit the anti-viral response by subverting the IFN functions to further its own propagation and infectability. We discuss here how the SARS-CoV-2 may also subvert the immune response of the lung macrophages, which also express ACE2, to exacerbate the severity of the COVID-19 respiratory symptoms. SARS-CoV-2 Subversion of the Antiviral Interferon Alpha-Response of Lung Macrophages? Malgorzata Kloc1,2,3*, Rafik M. Ghobrial1,2, Jacek Z Kubiak4,5* 1The Houston Methodist Research Institute, Houston, Texas 77030, USA 2The Houston Methodist Hospital, Department of Surgery, Houston, Texas, USA 3The University of Texas, M.D. Anderson Cancer Center, Department of Genetics, Houston Texas, USA 4Laboratory of Regenerative Medicine and Cell Biology, Military Institute of Hygiene and Epidemiology (WIHE), Warsaw, Poland 5UnivRennes, UMR 6290, CNRS, Institute of Genetics and Development of Rennes, Cell Cycle Group, Faculty of Medicine, Rennes, France","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75299021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnostic and Prognostic value of Immunohistochemistry in Destructive Paediatric Maxillary Pathologies 免疫组织化学对小儿上颌破坏性病变的诊断及预后价值
Pub Date : 2020-09-01 DOI: 10.29245/2578-3009/2020/3.1192
P. Jeyaraj
Introduction: Establishing an accurate diagnosis and probable prognosis of ambiguous, extensive and destructive maxillary pathologies, is imperative for an appropriate, timely and effective treatment modality to be instituted. This is particularly true in the paediatric population, in order to ensure complete elimination of the lesion, with the least possible morbidity, debility, or interference with normal jaw growth.
前言:对模糊性、广泛性和破坏性的上颌病变进行准确的诊断和可能的预后,是建立适当、及时、有效的治疗模式的必要条件。在儿科人群中尤其如此,为了确保完全消除病变,尽可能减少发病率、衰弱或对正常颌骨生长的干扰。
{"title":"Diagnostic and Prognostic value of Immunohistochemistry in Destructive Paediatric Maxillary Pathologies","authors":"P. Jeyaraj","doi":"10.29245/2578-3009/2020/3.1192","DOIUrl":"https://doi.org/10.29245/2578-3009/2020/3.1192","url":null,"abstract":"Introduction: Establishing an accurate diagnosis and probable prognosis of ambiguous, extensive and destructive maxillary pathologies, is imperative for an appropriate, timely and effective treatment modality to be instituted. This is particularly true in the paediatric population, in order to ensure complete elimination of the lesion, with the least possible morbidity, debility, or interference with normal jaw growth.","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87509482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bispecific Antibodies as an Alternative to Antibody Cocktails for SARS-CoV-2: A Mini- Review 双特异性抗体替代鸡尾酒抗体治疗SARS-CoV-2的研究综述
Pub Date : 2020-06-16 DOI: 10.29245/2578-3009/2022/2.1237
Gavin Yuen, S. Bhanot, Jeremy Steen, Minahil Syed, A. Mardon
Vaccination is a powerful inducer of immunity against SARS-CoV-2 and its recent variants. However, it is important to expand the defensive repertoire against this virus as vaccination is not always efficacious or accessible to everyone. Protein therapeutics in the form of monoclonal antibodies have been used to neutralize the Spike protein, but their efficacy has been limited with rapidly evolving mutations. Cocktail antibodies have been used to combat antigenic escape through diversifying antigen recognition and the overall neutralization capacity. However, the production of cocktail antibodies can be costly and requires a high dosage to achieve the desired therapeutic effect. Alternatively, bispecific antibodies have been used, which contain two recognition specificities within the same molecule. This effectively reduces the cost of production and dosage required to achieve a target therapeutic effect. Bispecific antibodies were reported to bind SARS-CoV-2 antigen with nanomolar affinities. The neutralization potentials (IC50 values) within the same studies were generally more efficacious than their cocktail antibody counterparts. Some studies showed that bispecific antibodies could also confer additional neutralization effector functions, such as recruiting the complement system. Although the recognition of variants was diverse, to our knowledge, there is no data to suggest that bispecific antibodies have a broader recognition of variant strains than cocktail antibodies. Future studies should aim to explore the clinical benefits of bispecific antibodies for SARS-CoV-2 and the emerging variant strains to better understand its benefits in treatment.
疫苗接种是对SARS-CoV-2及其最近变种的免疫的有力诱导剂。然而,重要的是扩大针对这种病毒的防御手段,因为疫苗接种并不总是有效或对每个人都可获得。单克隆抗体形式的蛋白质疗法已被用于中和Spike蛋白,但其疗效受到快速进化突变的限制。鸡尾酒抗体已被用于通过多样化抗原识别和整体中和能力来对抗抗原逃逸。然而,鸡尾酒抗体的生产可能是昂贵的,并且需要高剂量才能达到预期的治疗效果。另外,双特异性抗体已被使用,其在同一分子中包含两种识别特异性。这有效地降低了生产成本和达到目标治疗效果所需的剂量。据报道,双特异性抗体以纳摩尔亲和力结合SARS-CoV-2抗原。在相同的研究中,中和电位(IC50值)通常比鸡尾酒抗体更有效。一些研究表明,双特异性抗体还可以赋予额外的中和效应功能,如招募补体系统。虽然对变异的识别是多种多样的,但据我们所知,没有数据表明双特异性抗体比鸡尾酒抗体对变异菌株有更广泛的识别。未来的研究应旨在探索针对SARS-CoV-2和新出现的变异株的双特异性抗体的临床益处,以更好地了解其治疗益处。
{"title":"Bispecific Antibodies as an Alternative to Antibody Cocktails for SARS-CoV-2: A Mini- Review","authors":"Gavin Yuen, S. Bhanot, Jeremy Steen, Minahil Syed, A. Mardon","doi":"10.29245/2578-3009/2022/2.1237","DOIUrl":"https://doi.org/10.29245/2578-3009/2022/2.1237","url":null,"abstract":"Vaccination is a powerful inducer of immunity against SARS-CoV-2 and its recent variants. However, it is important to expand the defensive repertoire against this virus as vaccination is not always efficacious or accessible to everyone. Protein therapeutics in the form of monoclonal antibodies have been used to neutralize the Spike protein, but their efficacy has been limited with rapidly evolving mutations. Cocktail antibodies have been used to combat antigenic escape through diversifying antigen recognition and the overall neutralization capacity. However, the production of cocktail antibodies can be costly and requires a high dosage to achieve the desired therapeutic effect. Alternatively, bispecific antibodies have been used, which contain two recognition specificities within the same molecule. This effectively reduces the cost of production and dosage required to achieve a target therapeutic effect. Bispecific antibodies were reported to bind SARS-CoV-2 antigen with nanomolar affinities. The neutralization potentials (IC50 values) within the same studies were generally more efficacious than their cocktail antibody counterparts. Some studies showed that bispecific antibodies could also confer additional neutralization effector functions, such as recruiting the complement system. Although the recognition of variants was diverse, to our knowledge, there is no data to suggest that bispecific antibodies have a broader recognition of variant strains than cocktail antibodies. Future studies should aim to explore the clinical benefits of bispecific antibodies for SARS-CoV-2 and the emerging variant strains to better understand its benefits in treatment.","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86765088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary: An Allele-Specific Functional SNP Associated with Two Systemic Autoimmune Diseases Modulates IRF5 Expression by Long-Range Chromatin Loop Formation 评论:与两种系统性自身免疫疾病相关的一个等位基因特异性功能 SNP 通过长程染色质环形成调节 IRF5 的表达
Pub Date : 2020-03-01 DOI: 10.29245/2578-3009/2020/1.1182
Hlaing Nwe Thynn, Xiao-Feng Chen, Shanshan Dong, Yan Guo, Tie-Lin Yang
© 2020 Yang TL. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License. Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) are two typical inflammatory systemic autoimmune diseases sharing similar pathogenic features. Genetic factors play important roles in the pathogenesis of both diseases1. We have witnessed huge success of genome-wide association studies (GWASs) in identifying hundreds of susceptibility genetic variants associated with SLE and SSc, however, over 90% of which are located in noncoding regions. It is challenging and important to translate GWAS findings into biological insights towards clinical applications. Currently, compared with traditional genetic association studies, functional studies characterizing causal functional variants and downstream molecular mechanisms at disease susceptibility loci are still orders of magnitude fewer.
© 2020 Yang TL.本文采用知识共享署名 4.0 国际许可协议发布。系统性红斑狼疮(SLE)和系统性硬化症(SSc)是两种典型的炎症性系统性自身免疫疾病,具有相似的发病特征。遗传因素在这两种疾病的发病机制中起着重要作用1。我们已经见证了全基因组关联研究(GWAS)在鉴定与系统性红斑狼疮和系统性硬化相关的数百个易感基因变异方面取得的巨大成功,然而,其中超过 90% 的变异位于非编码区。如何将 GWAS 研究结果转化为临床应用的生物学洞察力,是一项具有挑战性的重要工作。目前,与传统的遗传关联研究相比,表征疾病易感基因位点的因果功能变异和下游分子机制的功能研究仍然少得多。
{"title":"Commentary: An Allele-Specific Functional SNP Associated with Two Systemic Autoimmune Diseases Modulates IRF5 Expression by Long-Range Chromatin Loop Formation","authors":"Hlaing Nwe Thynn, Xiao-Feng Chen, Shanshan Dong, Yan Guo, Tie-Lin Yang","doi":"10.29245/2578-3009/2020/1.1182","DOIUrl":"https://doi.org/10.29245/2578-3009/2020/1.1182","url":null,"abstract":"© 2020 Yang TL. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License. Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) are two typical inflammatory systemic autoimmune diseases sharing similar pathogenic features. Genetic factors play important roles in the pathogenesis of both diseases1. We have witnessed huge success of genome-wide association studies (GWASs) in identifying hundreds of susceptibility genetic variants associated with SLE and SSc, however, over 90% of which are located in noncoding regions. It is challenging and important to translate GWAS findings into biological insights towards clinical applications. Currently, compared with traditional genetic association studies, functional studies characterizing causal functional variants and downstream molecular mechanisms at disease susceptibility loci are still orders of magnitude fewer.","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141227873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects 器官移植免疫抑制药物预防同种异体移植排斥反应:作用方式和副作用
Pub Date : 2019-11-01 DOI: 10.29245/2578-3009/2019/4.1178
Elisa Claeys, K. Vermeire
Organ transplantation is a life-saving therapeutic intervention that contributes to a better quality of life in patients with end-stage organ failure. Drastically improved outcome after organ transplantation occurred with the discovery and use of immunosuppressive drugs to prevent or treat allograft rejection. Development of several immunosuppressive agents offers the option for a multidrug approach with non-overlapping toxicities. Still, the side effects of these agents can be severe, resulting in a shorter life expectancy for transplant patients compared to the general population. Therefore, the development of new immunosuppressive therapies that promote immune tolerance without the side effects observed today is needed. In this review, we will discuss the mechanism of allograft rejection as well as the mode of action and side effects of currently used immunosuppressive agents. Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects
器官移植是一种挽救生命的治疗干预,有助于改善终末期器官衰竭患者的生活质量。随着免疫抑制药物预防或治疗同种异体移植排斥反应的发现和使用,器官移植后的预后得到了显著改善。几种免疫抑制剂的发展为多药治疗提供了一种不重叠毒性的选择。尽管如此,这些药物的副作用可能很严重,导致移植患者的预期寿命比一般人群短。因此,需要开发新的免疫抑制疗法,以促进免疫耐受,而没有今天观察到的副作用。在这篇综述中,我们将讨论同种异体移植排斥反应的机制以及目前使用的免疫抑制剂的作用方式和副作用。器官移植免疫抑制药物预防同种异体移植排斥反应:作用方式和副作用
{"title":"Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects","authors":"Elisa Claeys, K. Vermeire","doi":"10.29245/2578-3009/2019/4.1178","DOIUrl":"https://doi.org/10.29245/2578-3009/2019/4.1178","url":null,"abstract":"Organ transplantation is a life-saving therapeutic intervention that contributes to a better quality of life in patients with end-stage organ failure. Drastically improved outcome after organ transplantation occurred with the discovery and use of immunosuppressive drugs to prevent or treat allograft rejection. Development of several immunosuppressive agents offers the option for a multidrug approach with non-overlapping toxicities. Still, the side effects of these agents can be severe, resulting in a shorter life expectancy for transplant patients compared to the general population. Therefore, the development of new immunosuppressive therapies that promote immune tolerance without the side effects observed today is needed. In this review, we will discuss the mechanism of allograft rejection as well as the mode of action and side effects of currently used immunosuppressive agents. Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78526158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
Immunometabolic Links Underlying the Infectobesity with Persistent Viral Infections 免疫代谢与持续性病毒感染之间的联系
Pub Date : 2019-08-01 DOI: 10.29245/2578-3009/2019/4.1176
Yongming Sang
Obesity and its related comorbidities are prevailing globally. Multiple factors are etiological to cause obesity and relevant metabolic disorders. In this regard, some pathogenic infections including those by viruses have also been associated with obesity (termed especiallky as infectobesity). In this mini-review, I examined recent publications about primary or cofactorial role of viral infections to exacerbate the local and systemic immunometabolic cues that underlie most cofactorial obesity. Major immuno-metabolic pathways involved, including that mediated by interferon (IFN) signaling and peroxisome proliferator activated receptor-γ (PPAR-γ), are discussed. at an inter-systemic level. While excess intake of energy-dense food (such as high-fat diet, HFD) forms a substantial physical factor for adipogenesis, active molecules derived from diet-microbiota interaction in gut, such as short- or long-chain fatty acid (LFA) in HFD, dramatically alter immune and metabolic homeostasis locally and systemically that entails obesity — a globally prevalent disease at the interface of immunity and metabolism involving multiple organs in digestive, endocrine and nervous systems. Major immunological links underlying obesity including local and systemic inflammation, altered cytokine and hormonal regulation, activated immune cells (macrophages, T cells etc.) as briefly listed by each major organ in obesogenesis. From an immunological view, some infections, particularly chronic viral infections as focused here, are associated and even form a reciprocal causality with obesity through their pathogenic intervention with host immune and metabolic systems at various stages of obesity development. Abbreviations: FA, fatty acid; IFN, interferon;
肥胖及其相关合并症在全球普遍存在。肥胖及相关代谢紊乱的病因有多种。在这方面,包括病毒感染在内的一些致病性感染也与肥胖(特别称为感染性肥胖)有关。在这篇小型综述中,我检查了最近发表的关于病毒感染加剧局部和全身免疫代谢信号的主要或辅助作用的文章,这些信号是大多数协因肥胖的基础。主要涉及的免疫代谢途径,包括干扰素(IFN)信号和过氧化物酶体增殖物激活受体-γ (PPAR-γ)介导的,进行了讨论。在系统间的层面上。虽然过量摄入能量密集的食物(如高脂肪饮食,HFD)是脂肪形成的重要物理因素,但肠道中来自饮食-微生物群相互作用的活性分子,如HFD中的短链或长链脂肪酸(LFA),会显著改变局部和全身的免疫和代谢稳态,导致肥胖——一种涉及消化、内分泌和神经系统等多个器官的免疫和代谢界面的全球流行疾病。肥胖的主要免疫学联系包括局部和全身性炎症、细胞因子和激素调节的改变、免疫细胞(巨噬细胞、T细胞等)的激活,这些都是肥胖发生的主要器官。从免疫学的角度来看,一些感染,特别是慢性病毒感染,通过在肥胖发展的各个阶段对宿主免疫和代谢系统的致病干预,与肥胖相关,甚至形成了相互的因果关系。缩写:FA,脂肪酸;干扰素干扰素;
{"title":"Immunometabolic Links Underlying the Infectobesity with Persistent Viral Infections","authors":"Yongming Sang","doi":"10.29245/2578-3009/2019/4.1176","DOIUrl":"https://doi.org/10.29245/2578-3009/2019/4.1176","url":null,"abstract":"Obesity and its related comorbidities are prevailing globally. Multiple factors are etiological to cause obesity and relevant metabolic disorders. In this regard, some pathogenic infections including those by viruses have also been associated with obesity (termed especiallky as infectobesity). In this mini-review, I examined recent publications about primary or cofactorial role of viral infections to exacerbate the local and systemic immunometabolic cues that underlie most cofactorial obesity. Major immuno-metabolic pathways involved, including that mediated by interferon (IFN) signaling and peroxisome proliferator activated receptor-γ (PPAR-γ), are discussed. at an inter-systemic level. While excess intake of energy-dense food (such as high-fat diet, HFD) forms a substantial physical factor for adipogenesis, active molecules derived from diet-microbiota interaction in gut, such as short- or long-chain fatty acid (LFA) in HFD, dramatically alter immune and metabolic homeostasis locally and systemically that entails obesity — a globally prevalent disease at the interface of immunity and metabolism involving multiple organs in digestive, endocrine and nervous systems. Major immunological links underlying obesity including local and systemic inflammation, altered cytokine and hormonal regulation, activated immune cells (macrophages, T cells etc.) as briefly listed by each major organ in obesogenesis. From an immunological view, some infections, particularly chronic viral infections as focused here, are associated and even form a reciprocal causality with obesity through their pathogenic intervention with host immune and metabolic systems at various stages of obesity development. Abbreviations: FA, fatty acid; IFN, interferon;","PeriodicalId":73785,"journal":{"name":"Journal of immunological sciences","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79408067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of immunological sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1